← Back to CMND

Clearmind Medicine Inc. - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJan 2026Filed 12/03/2026Jul 2025Filed 11/09/2025Apr 2025Filed 12/06/2025Jan 2025Filed 12/03/2026Jul 2024Filed 11/09/2025Apr 2024Filed 12/06/2025Jan 2024Filed 13/03/2025Jul 2023Filed 16/09/2024
−$3.9−$1.1−$2.1−$0.9−$1.4−$0.6
−$3.32−$0.25−$0.16−$9.55−$0.59−$0.28−$0.90−$2.43

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.